Ritter M - Search Results

1

Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.

Cox A, Klümper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, Erben P, Wirtz RM, Wullich B, Ritter M, Hölzel M, Schwamborn K, Horn T, Gschwend J, Hartmann A, Weichert W, Erlmeier F, Eckstein M. Cox A, et al. Among authors: ritter m. Eur Urol. 2024 Apr;85(4):328-332. doi: 10.1016/j.eururo.2023.03.020. Epub 2023 Apr 6. Eur Urol. 2024. PMID: 37031005 Free article.

2

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.

Krausewitz P, Fostitsch D, Weiten R, Kluemper N, Stein J, Luetkens J, Kristiansen G, Ellinger J, Ritter M. Krausewitz P, et al. Among authors: ritter m. World J Urol. 2023 Jan;41(1):19-25. doi: 10.1007/s00345-022-04230-w. Epub 2022 Dec 7. World J Urol. 2023. PMID: 36477403 Free PMC article.

3

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers.

von Danwitz M, Klümper N, Bernhardt M, Cox A, Krausewitz P, Alajati A, Kristiansen G, Ritter M, Ellinger J, Stein J. von Danwitz M, et al. Among authors: ritter m. Cancers (Basel). 2023 Mar 21;15(6):1890. doi: 10.3390/cancers15061890. Cancers (Basel). 2023. PMID: 36980776 Free PMC article.

4

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial.

Saal J, Bald T, Eckstein M, Ritter M, Brossart P, Ellinger J, Hölzel M, Klümper N. Saal J, et al. Among authors: ritter m. JNCI Cancer Spectr. 2023 Mar 1;7(2):pkad027. doi: 10.1093/jncics/pkad027. JNCI Cancer Spectr. 2023. PMID: 37004206 Free PMC article.

5

Depletion of the m⁶A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.

Hu W, Klümper N, Schmidt D, Ritter M, Ellinger J, Hauser S. Hu W, et al. Among authors: ritter m. Am J Transl Res. 2023 Mar 15;15(3):1744-1755. eCollection 2023. Am J Transl Res. 2023. PMID: 37056835 Free PMC article.

6

Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma.

Saal J, Bald T, Eckstein M, Ralser DJ, Ritter M, Brossart P, Grünwald V, Hölzel M, Ellinger J, Klümper N. Saal J, et al. Among authors: ritter m. JAMA Oncol. 2023 Aug 1;9(8):1048-1055. doi: 10.1001/jamaoncol.2023.1822. JAMA Oncol. 2023. PMID: 37347489 Free PMC article.

7

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.

Klümper N, Wüst L, Saal J, Ralser DJ, Zarbl R, Jarczyk J, Breyer J, Sikic D, Wullich B, Bolenz C, Roghmann F, Hölzel M, Ritter M, Strieth S, Hartmann A, Erben P, Wirtz RM, Landsberg J, Dietrich D, Eckstein M. Klümper N, et al. Among authors: ritter m. Oncoimmunology. 2023 Oct 19;12(1):2267744. doi: 10.1080/2162402X.2023.2267744. eCollection 2023. Oncoimmunology. 2023. PMID: 37868689 Free PMC article.

8

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.

Saal J, Ellinger J, Ritter M, Brossart P, Hölzel M, Klümper N, Bald T. Saal J, et al. Among authors: ritter m. Clin Transl Immunology. 2023 Nov 8;12(11):e1472. doi: 10.1002/cti2.1472. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37946873 Free PMC article.

9

On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy.

Saal J, Grünwald V, Bald T, Ritter M, Brossart P, Tomita Y, Hartmann A, Hölzel M, Eckstein M, Klümper N. Saal J, et al. Among authors: ritter m. Eur Urol Oncol. 2023 Nov 22:S2588-9311(23)00250-X. doi: 10.1016/j.euo.2023.11.005. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37996277

10

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

Stein J, Krappe E, Kremer A, Cronauer MV, Essler M, Cox A, Klümper N, Krausewitz P, Ellinger J, Ritter M, Kristiansen G, Majores M. Stein J, et al. Among authors: ritter m. J Cancer Res Clin Oncol. 2024 Feb 4;150(2):76. doi: 10.1007/s00432-023-05579-0. J Cancer Res Clin Oncol. 2024. PMID: 38310601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,843 results

Search Page